| Entry |
|
|---|
| Name |
Acyclovir and hydrochortisone;
Xerese (TN) |
|---|
| Product |
XERESE (Bausch Health US LLC) |
|---|
| Component |
Acyclovir [DR:D00222], Hydrocortisone [DR:D00088]
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiviral |
|---|
| Disease |
Herpes labialis [DS:H00365] |
|---|
| Target |
Herpesvirus DNA polymerase [KO:K18964] |
|---|
| Pathway |
| ko03240 | Viral replication |
|
|---|
| Brite |
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Dermatological Agents, Combinations
Acyclovir/ Hydrocortisone
D11627 Acyclovir and hydrochortisone
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Herpesvirus DNA polymerase inhibitor
D11627 Acyclovir and hydrochortisone <US>
|
|---|
| Other DBs |
|
|---|